A Study of Belantamab Mafodotin (GSK2857916) in Multiple Myeloma Participants With Normal and Impaired Renal Function
about
A Study of Belantamab Mafodotin (GSK2857916) in Multiple Myeloma Participants With Normal and Impaired Renal Function
description
clinical trial
@en
ensayo clínico
@es
klinisch onderzoek
@nl
name
A Study of Belantamab Mafodoti ...... al and Impaired Renal Function
@en
A Study of Belantamab Mafodoti ...... al and Impaired Renal Function
@nl
type
label
A Study of Belantamab Mafodoti ...... al and Impaired Renal Function
@en
A Study of Belantamab Mafodoti ...... al and Impaired Renal Function
@nl
prefLabel
A Study of Belantamab Mafodoti ...... al and Impaired Renal Function
@en
A Study of Belantamab Mafodoti ...... al and Impaired Renal Function
@nl
P1476
A Phase I Study to Evaluate th ...... red Renal Function (DREAMM 12)
@en
P3098
NCT04398745
P580
2020-07-30T00:00:00Z
P582
2024-09-23T00:00:00Z